Abstract
MAMMALIAN cell-cycle control by antimitogenic signals involves p21Cip1/WAF1(refs 1–4), p27Kip1 (refs 5,6) andp57Kip2(refs 7,8) a family of proteins that bind to and inhibit cyclin-dependent kinases (CDKs) required for initiation of S phase. The protein p21 also binds to the DNA polymerase δ processivity factor, proliferating-cell nuclear antigen (PCNA), and inhibits in vitro PCNA-dependent DNA replication9,10. The CDK and PCNA inhibitory activities of p21 are shown here to be functionally independent and to reside in separate protein domains. The PCNA binding and inhibitory activities, which are not observed with p27 or p57, reside in the C-terminal domain of p21, whereas the CDK inhibitory activity resides in the conserved N-terminal domains of these proteins. When separately overexpressed in mammalian cells, the CDK and PCNA inhibitory domains prevent DNA replication, demonstrating a dual function of p21 as a cell-cycle inhibitor in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
El-Deiry, W. S. et al. Cell 75, 817–825 (1993).
Gu, Y., Turck, C. W. & Morgan, D. O. Nature 366, 707–710 (1993).
Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. Cell 75, 805–816 (1993).
Xiong, Y. et al. Nature 366, 701–704 (1993).
Polyak, K. et al. Cell 78, 59–66 (1994).
Toyoshima, H. & Hunter, T. Cell 78, 67–74 (1994).
Lee, M.-H., Reynisdóttir, I. & Massagué, J. Genes Dev. 9, 639–649 (1995).
Matsuoka, S. et al. Genes Dev. 9, 650–662 (1995).
Waga, S., Hannon, G. J., Beach, D. & Stillman, B. Nature 369, 574–578 (1994).
Flores-Rozas, H. et al. Proc. natn. Acad. Sci. U.S.A. 91, 8655–8659 (1994).
Attisano, L. et al. Cell 75, 671–680 (1993).
Kalderon, D., Roberts, B. L., Richardson, W. D. & Smith, A. E. Cell 39, 499–509 (1984).
Matsushime, H. et al. Cell 71, 323–334 (1992).
Kelman, Z., Naktinis, V. & O'Donnell, M. Meth. Enzym. (in the press).
Desai, D., Gu, Y. & Morgan, D. O. Molec. Biol. Cell 3, 571–582 (1992).
Kato, J., Matsuoka, M., Potyak, K., Massagué, J. & Sherr, C. J. Cell 79, 487–496 (1994).
Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M. & Massagué, J. Cell 62, 175–185 (1990).
Warbrick, E., Lane, D. P., Glover, D. M. & Cox, L. S. Curr. Biol. 5, 275–282 (1995).
Chen, J., Jackson, P. K., Kirschner, M. W. & Dutta, A. Nature 374, 386–388 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Luo, Y., Hurwitz, J. & Massagué, J. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375, 159–161 (1995). https://doi.org/10.1038/375159a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/375159a0
This article is cited by
-
CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma
Cell Death & Disease (2022)
-
Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2
Nature Communications (2021)
-
Anti-proliferative activities of Byrsocarpus coccineus Schum. and Thonn. (Connaraceae) using ovarian cancer cell lines
Journal of Ovarian Research (2020)
-
Poldip2 knockdown inhibits vascular smooth muscle proliferation and neointima formation by regulating the expression of PCNA and p21
Laboratory Investigation (2019)
-
The AHR represses nucleotide excision repair and apoptosis and contributes to UV-induced skin carcinogenesis
Cell Death & Differentiation (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.